Digest Network Come funziona
Network
/
Società
CD
Non verificato

CDR-Life

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

7 comunicati stampa

Guarda tutti i comunicati
26/06/2025
Oncologia
Salute
Attrezzature medico-sanitarie
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
CDR-Life Announces CDR609 as New T-Cell Engager Clinical Candidate Targeting LGR5, a Highly Cancer-specific Surface Antigen Widely Expressed on Common Solid Tumor
Fonte
CDR-Life
Emittente
Business Wire
1.00
0
28/05/2025
Oncologia
Salute
Biologia
Medicina - Varie
Farmaceutica
Biotecnologia
Mercato del lavoro
CDR-Life Appoints Pascal Touchon to the Board of Directors to Support Continued Growth and Advancement of Next Generation T Cell Engager Platform
Fonte
CDR-Life
Emittente
Business Wire
1.00
0
25/04/2025
Eventi
Fiere
Industria
Oncologia
Salute
Biologia
Medicina - Varie
Farmaceutica
Biotecnologia
CDR-Life Presents Promising Preclinical Data for Novel T Cell Engager Programs at AACR Annual Meeting 2025
Fonte
CDR-Life
Emittente
Business Wire
1.00
0
25/03/2025
Eventi
Industria
Biotecnologia
Salute
Oncologia
Medicina - Varie
CDR-Life Demonstrates Commitment to Differentiated Pipeline with New Autoimmune Candidate CDR111
Fonte
CDR-Life
Emittente
Business Wire
1.00
0
25/02/2025
Scienza
Biotecnologia
Farmaceutica
Ottica
Oncologia
Salute
Medicina - Varie
Mercato del lavoro
Industria
CDR-Life Announces Fifth Milestone Achievement with Boehringer Ingelheim in Geographic Atrophy
Fonte
CDR-Life
Emittente
Business Wire
1.00
0
05/12/2024
Mercato del lavoro
Oncologia
Salute
Scienza
Farmaceutica
Biotecnologia
CDR-Life Appoints Sarah Holland, PhD, as Chief Business Officer
Fonte
CDR-Life
Emittente
Business Wire
1.00
0
13/09/2024
Eventi
Industria
Oncologia
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
CDR-Life Announces Pipeline Progress of M-gager® Programs for Treatment of Solid Tumors
Fonte
CDR-Life
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0